These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8819224)

  • 1. Induction of antinuclear antibody after interferon therapy in patients with type-C chronic hepatitis: its relation to the efficacy of therapy.
    Noda K; Enomoto N; Arai K; Masuda E; Yamada Y; Suzuki K; Tanaka M; Yoshihara H
    Scand J Gastroenterol; 1996 Jul; 31(7):716-22. PubMed ID: 8819224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers.
    Okazaki T; Yoshihara H; Suzuki K; Yamada Y; Tsujimura T; Kawano K; Yamada Y; Abe H
    Scand J Gastroenterol; 1994 Nov; 29(11):1039-43. PubMed ID: 7871371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation.
    Van Thiel DH; Molloy PJ; Friedlander L; Kania RJ; Fagiuoli S; Caraceni P; Wright HI; Zuhdi N
    Hepatogastroenterology; 1995; 42(6):900-6. PubMed ID: 8847043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.
    Aiyama T; Yoshioka K; Hirofuji H; Kusakabe A; Yamada M; Tanaka K; Kakumu S
    Dig Dis Sci; 1994 Oct; 39(10):2244-9. PubMed ID: 7924750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
    Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
    Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and clinical significance of antinuclear antibody in hepatitis C virus infection.
    Peng YC; Hsieh SC; Yang DY; Tung CF; Hu WH; Huang WN; Chen GH
    J Clin Gastroenterol; 2001; 33(5):402-6. PubMed ID: 11606858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies during alpha-interferon therapy for chronic hepatitis B.
    Fattovich G; Betterle C; Brollo L; Pedini B; Giustina G; Realdi G; Alberti A; Ruol A
    J Med Virol; 1991 Jun; 34(2):132-5. PubMed ID: 1890413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis.
    Mochida S; Ohnishi K; Matsuo S; Kakihara K; Fujiwara K
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):371A-377A. PubMed ID: 8986241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity during alpha-interferon therapy for chronic hepatitis C.
    Yoshikawa M; Sakamoto T; Mitoro A; Mochi T; Tsujii H; Koizumi M; Yoshiji H; Sakaguchi Y; Fukui H; Nakano H
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():109-14. PubMed ID: 8359620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients.
    Hsieh MY; Dai CY; Lee LP; Huang JF; Chuang WL; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Yu ML
    Kaohsiung J Med Sci; 2012 Feb; 28(2):86-93. PubMed ID: 22313535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon?
    Narciso-Schiavon JL; Freire FC; Suarez MM; Ferrari MV; Scanhola GQ; Schiavon Lde L; de Carvalho Filho RJ; Ferraz ML; Silva AE
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):440-6. PubMed ID: 19382301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with interferon alfa-2b in patients with chronic hepatitis caused by hepatitis C virus: predictive factors for the response, relapse and early development to cirrhosis after treatment].
    Pérez Roldán F; De Diego A; Casado M; Matilla A; Bañares R; García-Durán F; Salcedo M; Cos E; Clemente G
    Rev Esp Enferm Dig; 1996 Sep; 88(9):609-15. PubMed ID: 8962775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of interferons in treating children with chronic hepatitis C.
    Matsuoka S; Mori K; Nakano O; Yuasa Y; Taguchi Y; Hayabuchi Y; Kuroda Y
    Eur J Pediatr; 1997 Sep; 156(9):704-8. PubMed ID: 9296534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.
    Senturk H; Uzunalimoglu O; Batur Y; Simsek I; Mert A; Ozbay G; Cetinkaya H; Ersoz G; Tabak F; Akbaylar H; Akdogan M; Dokmeci A; Sonsuz A; Ozenirler S; Erden E; Tozum N
    Dig Dis Sci; 1997 Jul; 42(7):1438-44. PubMed ID: 9246043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha interferon treatment in chronic hepatitis C.
    Idéo G; Bellobuono A; Mondazzi L; Tempini S; Bellati G; Idéo GM; Silini E
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S167-73. PubMed ID: 8730501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha.
    Matsuda J; Saitoh N; Gotoh M; Gohchi K; Tsukamoto M; Syoji S; Miyake K; Yamanaka M
    Am J Gastroenterol; 1995 Jul; 90(7):1138-41. PubMed ID: 7611213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus RNA and anti-N14 antibody levels during interferon alpha therapy for chronic hepatitis C.
    Oketani M; Tanaka K; Sho Y; Maeda E; Miyazaki H; Arima T
    Intern Med; 1994 Oct; 33(10):588-92. PubMed ID: 7530068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.
    Marazuela M; García-Buey L; González-Fernández B; García-Monzón C; Arranz A; Borque MJ; Moreno-Otero R
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):635-42. PubMed ID: 8759175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.